R&D | December 29, 2025
Akums and Sharda University ink MoU to bridge industry–academia gap
The primary goal of the collaboration is joint research into trending and next-generation molecules
The primary goal of the collaboration is joint research into trending and next-generation molecules
These observations are procedural in nature and the company does not anticipate any impact on supply of its commercial products
This development marks a substantial improvement in the company's financial position and reflects strengthened promoter confidence
The new facility is expected to generate 500-600 new jobs in the region
The FDA aims to make a decision by April 8, 2026
At the trial’s pre-specified interim analysis, giredestrant achieved a hazard ratio of 0.70, marking a statistically significant improvement in invasive disease-free survival
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
The partnership targets breakthroughs in Alzheimer’s disease, diabetes, cancer, and cell and gene therapy
FDA's withholding of the PRV was contrary to law because no drug product containing phenobarbital sodium was 'previously approved'
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Subscribe To Our Newsletter & Stay Updated
